Holen Sie sich die Stockscreener-App
51.40
1.81%
-0.95
Handel nachbörslich:
50.68
-0.72
-1.40%
Schlusskurs vom Vortag:
$52.35
Offen:
$51.6
24-Stunden-Volumen:
81.03M
Relative Volume:
2.48
Marktkapitalisierung:
$8.09B
Einnahmen:
$1.24B
Nettoeinkommen (Verlust:
$101.26M
KGV:
116.82
EPS:
0.44
Netto-Cashflow:
$149.62M
1W Leistung:
+42.15%
1M Leistung:
+96.93%
6M Leistung:
+119.56%
1J Leistung:
+323.05%
1-Tages-Spanne:
$50.04
$54.75
1-Wochen-Bereich:
$36.62
$54.75
52-Wochen-Spanne:
$12.07
$72.98
Hims Hers Health Inc Stock (HIMS) Company Profile
Firmenname
Hims Hers Health Inc
Sektor
Telefon
415-851-0195
Adresse
2269 CHESTNUT ST, SAN FRANCISCO
Vergleichen Sie HIMS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
51.40 | 8.09B | 1.24B | 101.26M | 149.62M | 0.44 |
|
PG
Procter Gamble Co
|
158.65 | 375.08B | 83.93B | 15.50B | 15.03B | 6.30 |
|
UL
Unilever Plc Adr
|
62.58 | 160.71B | 65.10B | 6.16B | 0 | 2.4569 |
|
CL
Colgate Palmolive Co
|
90.83 | 77.71B | 19.95B | 2.90B | 3.47B | 3.54 |
|
KVUE
Kenvue Inc
|
24.06 | 45.97B | 15.46B | 1.03B | 1.34B | 0.53 |
|
KMB
Kimberly Clark Corp
|
133.54 | 43.09B | 19.75B | 2.47B | 2.39B | 7.34 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-29 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-02-18 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-01-10 | Herabstufung | Citigroup | Neutral → Sell |
| 2025-01-07 | Eingeleitet | BTIG Research | Buy |
| 2024-12-17 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-11-14 | Herabstufung | BofA Securities | Buy → Underperform |
| 2024-08-22 | Eingeleitet | Needham | Buy |
| 2024-08-09 | Herabstufung | Imperial Capital | Outperform → In-line |
| 2024-05-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-04-16 | Herabstufung | Jefferies | Buy → Hold |
| 2024-04-10 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-02-28 | Hochstufung | Imperial Capital | In-line → Outperform |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2023-12-07 | Eingeleitet | Imperial Capital | In-line |
| 2023-07-28 | Eingeleitet | TD Cowen | Outperform |
| 2023-04-11 | Eingeleitet | Robert W. Baird | Neutral |
| 2023-02-09 | Hochstufung | Jefferies | Hold → Buy |
| 2022-11-08 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-11-08 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-17 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-07-15 | Eingeleitet | SVB Leerink | Underperform |
| 2022-04-14 | Eingeleitet | Guggenheim | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-03-10 | Eingeleitet | Deutsche Bank | Hold |
| 2021-12-02 | Eingeleitet | Jefferies | Hold |
| 2021-11-11 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-07-06 | Eingeleitet | BofA Securities | Neutral |
| 2021-05-20 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-04-21 | Eingeleitet | Truist | Hold |
| 2021-03-09 | Eingeleitet | Credit Suisse | Neutral |
| 2021-03-02 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-02-17 | Eingeleitet | Citigroup | Neutral |
| 2021-02-12 | Eingeleitet | Piper Sandler | Neutral |
| 2021-02-08 | Eingeleitet | Tigress Financial | Buy |
Alle ansehen
Hims Hers Health Inc Aktie (HIMS) Neueste Nachrichten
Hims & Hers Stock's 100% Surge Is Squeezing Shorts And It Might Just Be Getting Started - Benzinga
Hims & Hers names Amazon veteran as COO - Healthcare Dive
Hims & Hers hires former Amazon exec as Q1 revenue doubles - Retail Dive
Hims & Hers Appoints AI Expert and Former President and CTO at Cruise as Chief Technology Officer - 01net
Hims & Hers: The Road To Blue Chip Status (NYSE:HIMS) - Seeking Alpha
Hims & Hers Health Stock Is Sliding Thursday: What's Going On? - Benzinga
Hims & Hers Health to offer $450M convertible senior notes - MSN
Hims & Hers plans $450M convertible notes offering By Investing.com - Investing.com Canada
Hims & Hers shares fall on convertible notes offering By Investing.com - Investing.com Canada
Hims & Hers shares fall on convertible notes offering - Investing.com
Hims & Hers plans $450M convertible notes offering - Investing.com
Hims & Hers Soars Again--Explosive Growth Meets Lofty Expectations (NYSE:HIMS) - Seeking Alpha
Hims & Hers Health, Inc. Announces Proposed Convertible Senior Notes Offering to Accelerate Global Expansion and Utilization of AI in Healthcare - Bluefield Daily Telegraph
After Leaping 89% Hims & Hers Health, Inc. (NYSE:HIMS) Shares Are Not Flying Under The Radar - simplywall.st
Hims & Hers appoints Mo Elshenawy as CTO to boost AI healthcare - Investing.com
Hims & Hers Has a Superpower in Healthcare - Nasdaq
Superb Quarterly Report Opens Door to $100 Price Target on Hims & Hers Health Stock (HIMS) - TipRanks
Hims & Hers Has A Superpower In Healthcare - Barchart.com
How much a $1,000 investment in Hims & Hers at its IPO would be worth now - MSN
Hims & Hers Health Shocks Investors With a Long-Term Forecast, but Is the Stock a Buy? - AOL.com
Cofounder Of Hims, Seller Of Hair Loss And Erectile Dysfunction Pills, Is A Billionaire After Weight Loss Drug Deal - Forbes
Hims & Hers: 2030 Guidance Indicates Big Upside (NYSE:HIMS) - Seeking Alpha
Hims CEO Rides Weight-Loss Drug Boom to $1.1 Billion Fortune - Bloomberg.com
Hims & Hers Stock Soars 32% Since Tuesday On Strong Q1 Earnings And Robust Outlook - Benzinga
Surging Earnings Estimates Signal Upside for Hims & Hers Health (HIMS) Stock - Nasdaq
Hims & Hers: Short Squeeze Or Strong Fundamentals? (Rating Downgrade) (NYSE:HIMS) - Seeking Alpha
Hims & Hers Shows It's More Than Just GLP-1 Drugs - 24/7 Wall St.
Hims & Hers Health Inc. (HIMS) Stock: Monster Q1 Growth Can't Save Stock from After-Hours Tumble - CoinCentral
Hims & Hers Health, Inc. (NYSE:HIMS) Q1 2025 Earnings Call Transcript - MSN
Hims & Hers Health: Healthcare Disruptor Building A Durable Moat (Initiate With Buy) - Seeking Alpha
Hims & Hers Jumps 18.2% on Incredible 111% Revenue Growth - The Motley Fool
Why Hims & Hers Health, Inc. (HIMS) Skyrocketed On Tuesday - Yahoo Finance
Hims & Hers Stock (HIMS) Falls as Cautious Outlook Blurs Massive Revenue Growth - Yahoo Finance
What's Next For HIMS Stock After An Upbeat Q1? - Nasdaq
This Week's Healthcare Earnings: Moderna, CVS, Hims & Hers - Law360
Hims & Hers Health, Inc. Reports Strong Q1 Earnings - TipRanks
Piper Sandler Raises Price Target for Hims & Hers Health (HIMS) to $39.00 | HIMS Stock News - GuruFocus
Hims & Hers Health (HIMS) Surges 18.12%: What’s Fueling the Rally? - Wealth Daily
Stock Movers: Palantir, Hims, Constellation Energy - Bloomberg.com
What’s driving the roller coaster ride for San Francisco’s Hims & Hers stock? - San Francisco Chronicle
Hims & Hers Health (HIMS) Stock Trades Up, Here Is Why - Yahoo Finance
Palantir, Tesla, Ford, Constellation Energy, SolarEdge, Vertex, DoorDash, and More Movers - Barron's
Wall Street Punishes HIMS--Right After It Lands a Blockbuster Weight Loss Deal - Yahoo Finance
Noteworthy Tuesday Option Activity: ROOT, HIMS, SN - Nasdaq
Why Hims & Hers Stock Popped Tuesday, but Eli Lilly and Novo Nordisk Dropped - Nasdaq
2 Reasons Hims & Hers Will Break $50sBuy Post Earnings (NYSE:HIMS) - Seeking Alpha
HIMS Q1 Earnings Call: Personalized Care and New Partnerships Drive Upside, Guidance Signals Near-Term Transition - Yahoo Finance
HIMS Stock Dips Pre-Market Despite Q1 Earnings Beat, Gross Margin Down - Yahoo Finance
Hims & Hers Health (HIMS) Price Target Raised by Citigroup | HIMS Stock News - GuruFocus
Hims surges, SolarEdge earnings beat, Rivian expands in Illinois - Yahoo Finance
Hims & Hers stock jumps after blowout quarter, long-term guidance stuns Street - Proactive financial news
Finanzdaten der Hims Hers Health Inc-Aktie (HIMS)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.47%
0.04%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):